- Home
- PVL vs FORA Comparison
PVL vs FORA Comparison
Compare PVL & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PVL | FORA |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Computer Software: Prepackaged Software |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 66.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PVL | FORA |
|---|---|---|
| Price | $1.86 | $2.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 129.8K | 16.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.40% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,153,263.00 |
| Revenue This Year | N/A | $51.82 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | $26.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.30 | $1.64 |
| 52 Week High | $2.04 | $2.71 |
Technical Indicators
Market Signals| Indicator | PVL | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 49.61 |
| Support Level | $1.75 | $2.05 |
| Resistance Level | $1.88 | $2.12 |
| Average True Range (ATR) | 0.06 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 75.00 | 60.00 |
Price Performance
Historical ComparisonAbout PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.